Skip to main content
David Duncan, MD, Neurology, Neptune, NJ, Hackensack Meridian Health Jersey Shore University Medical Center

DavidBDuncanMD

Neurology Neptune, NJ

Neuroimmunology/Multiple Sclerosis

Director Jersey Shore University Medical Center MS Center

Dr. Duncan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Duncan's full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Nuclear Medicine, 1993 - 1995
  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineResidency, Neurology, 1988 - 1992
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 1988

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1995 - 2025
  • NJ State Medical License
    NJ State Medical License 2012 - 2025
  • PA State Medical License
    PA State Medical License 1994 - 1998
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2012-2014
  • Westchester Magazine: Top Doctors Castle Connolly, 2011, 2013
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2012

Publications & Presentations

PubMed

Press Mentions

  • Breakthrough Drug Offers Multiple Sclerosis Patients A Second Chance
    Breakthrough Drug Offers Multiple Sclerosis Patients A Second ChanceJune 14th, 2018
  • Hackensack Meridian’s Status as Comprehensive Care Center Renewed
    Hackensack Meridian’s Status as Comprehensive Care Center RenewedNovember 24th, 2023
  • FDA Approves the First Biosimilar Drug to Treat Multiple Sclerosis
    FDA Approves the First Biosimilar Drug to Treat Multiple SclerosisAugust 30th, 2023
  • Join now to see all

Other Languages

  • German

Hospital Affiliations